High-Sensitivity Cardiac Biomarker Market
High-Sensitivity Cardiac Biomarker Market By Diagnosis Type (CK-MB, Creatinine Kinase, Myoglobin,Cardiac Troponin) , By End User (Hospitals,Cardiology Clinics,Ambulatory Surgical,Centers,Specialty Clinics)-Global Market Insights 2018 to 2028
Analysis of High-Sensitivity Cardiac Biomarker Market Covering 30 + Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Market Overview
Many people suffer from cardiac problems, which can lead to major cardiac diseases. The use of high-sensitivity cardiac biomarkers provides real-time diagnosis for patients who are suffering from cardiac ischemia, ASC (acute coronary syndrome), and various other cardiac-related problems. The high-sensitivity cardiac biomarker is placed within the blood stream to identify the cardiac problem for checking the damage ratio of the heart, and also to find out the stress level of the heart. The diagnosis that the high-sensitivity cardiac biomarker can make determines the risk of the heart of the patient, which can be very helpful for treatment. A high-sensitivity cardiac biomarker is mostly used for the diagnosis for myoglobin, CK-MB, CK (creatinine kinase), and cardiac troponin, which can be a real-time protection for cardiac patients. The symptoms of cardiac ischemia along with acute coronary syndrome and other cardiac diseases are change in pressure, chest pain, nausea, and others, which can lead to cardiac problems. High-sensitivity cardiac biomarkers are much more effective than any other diagnosis methodology for cardiac problems. These high-sensitivity cardiac biomarkers are done at the point of care for cardiac patients.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
High-Sensitivity Cardiac Biomarker Market: Drivers and Restraints
The high-sensitivity cardiac biomarker market is expected to be a growing market over the forecast period, as the cardiac patient pool is high in various geographical regions, which directly boosts the market for high-sensitivity cardiac biomarkers.
According to CDC (Centers for Disease Control and Prevention), approx. 735,000 U.S. citizens are suffer from heart attacks every year. Out of these, around 525,000 experience a first-time heart attack, and approx. 210,000 have already experienced a heart attack in the past. The developed medical systems in some of the regions also directly boosts the market for high-sensitivity cardiac biomarkers. The high cost related to high-sensitivity cardiac biomarkers along with the lack of awareness among cardiac patients and health professionals are the current hindrances for the market for high-sensitivity cardiac biomarkers.
High-Sensitivity Cardiac Biomarker Market: Overview
The global high-sensitivity cardiac biomarker market is estimated to be a growing market, as cardiac-specialized hospitals and clinics are increasing in various regions, which directly boosts the market for high-sensitivity cardiac biomarkers. Industries along with various research organizations are working to develop new variants of high-sensitivity cardiac biomarkers that can be more accurate for monitoring cardiac problems in various age groups.
Among the end users, the hospitals segment holds a major market as the presence is high all the geographical regions and also due to high budget for healthcare segment to enhance the infrastructures in developing countries.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
High-Sensitivity Cardiac Biomarker Market: Regional Outlook
Geographically, the global high-sensitivity cardiac biomarker market is segmented into North America, Latin America, Europe, CIS & Russia, Japan, Asia Pacific excluding Japan (APEJ), and the Middle East & Africa (MEA). North America has a major market share, as the number of industry players present is high in the region, along with various reimbursement options, which directly affect the market for high-sensitivity cardiac biomarkers. Europe is expected to experience high growth rate, as the adoption rate for high-sensitivity cardiac biomarkers is increasing among healthcare professionals.
CIS & Russia are expected to experience increasing growth, as the adoption rate is increasing among end users for high-sensitivity cardiac biomarkers. Japan is expected to experience moderate growth, as the ageing population have a high risk of cardiac problems, which directly boosts the market of high-sensitivity cardiac biomarkers. Asia Pacific excluding Japan (APEJ) is expected to experience increasing growth, as the awareness about high-sensitivity cardiac biomarkers is increasing for the diagnosis of cardiac problems, along with the increasing medical infrastructure in various countries. The Middle East & Africa (MEA) is expected to experience slow growth, as the medical infrastructure is developing in these regions, along with the increasing awareness among healthcare professionals.
High-Sensitivity Cardiac Biomarker Market: Key Players
- Creative Diagnostics
- HyTest Ltd
- Biomedica
- Life Diagnostics Inc.
- Bio-Rad Laboratories
- Enzo Life Sciences Inc. (sub. of Enzo Biochem Inc.)
- Randox Laboratories Ltd
- Thermo Fisher Scientific
- Merck KGaA
- among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators, and governing factors, along with market attractiveness as per segment. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers exhaustive analysis on:
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved
- Technology
- Value Chain
Regional analysis includes
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Chile
- Peru
- Rest of LATAM
- Europe
- EU – 4 (Germany, France, Italy, Spain)
- U.K.
- BENELUX (Belgium, Netherlands, Luxemburg)
- NORDIC (Norway, Denmark, Iceland, Sweden)
- Eastern Europe (Poland, Ukraine, Czech Rep., etc.)
- Rest of Europe
- CIS & Russia
- Japan
- APEJ
- Greater China
- India
- S. Korea
- ASEAN Countries
- Rest of APEJ
- Middle East & Africa
- GCC Countries
- Turkey
- Iran
- Israel
- South Africa
- Rest of MEA
Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
High-Sensitivity Cardiac Biomarker Market: Segmentation
Tentatively, the global high-sensitivity cardiac biomarker market can be segmented on the basis of diagnosis type and end user.
Based on diagnosis type, the global high-sensitivity cardiac biomarker market is segmented as:
- CK-MB
- Creatinine Kinase
- Myoglobin
- Cardiac Troponin
- Others
Based on end user, the global high-sensitivity cardiac biomarker market is segmented as:
- Hospitals
- Cardiology Clinics
- Ambulatory Surgical Centers
- Specialty Clinics
- Others
Table of Content
1. Executive Summary 2. Industry Introduction, including Taxonomy and Market Definition 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections 5. Pricing Analysis 6. Global Market Analysis and Forecast 6.1. Diagnosis Type 6.2. End User 7. Global Market Analysis and Forecast, By Diagnosis Type 7.1. CK-MB 7.2. Creatinine Kinase 7.3. Myoglobin 7.4. Cardiac Troponin 7.5. Others 8. Global Market Analysis and Forecast, By End User 8.1. Hospitals 8.2. Cardiology Clinics 8.3. Ambulatory Surgical Centers 8.4. Specialty Clinics 8.5. Others 9. Global Market Analysis and Forecast, By Region 9.1. North America 9.2. Latin America 9.3. Western Europe 9.4. Eastern Europe 9.5. Asia Pacific 9.6. East Asia 9.7. MEA 10. North America Sales Analysis and Forecast, by Key Segments and Countries 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries 14. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries 16. MEA Sales Analysis and Forecast, by Key Segments and Countries 17. Sales Forecast by Diagnosis Type and End User for 30 Countries 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard 19. Company Profile 19.1. Creative Diagnostics 19.2. HyTest Ltd 19.3. Biomedica 19.4. Life Diagnostics Inc. 19.5. Bio-Rad Laboratories 19.6. Enzo Life Sciences Inc. (sub. of Enzo Biochem Inc.) 19.7. Randox Laboratories Ltd 19.8. Thermo Fisher Scientific 19.9. Merck KGaA
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Diagnosis Type
Table 3: Global Market US$ Mn Forecast by End User
Table 4: North America Market US$ Mn Forecast by Country
Table 5: North America Market US$ Mn Forecast by Diagnosis Type
Table 6: North America Market US$ Mn Forecast by End User
Table 7: Latin America Market US$ Mn Forecast by Country
Table 8: Latin America Market US$ Mn Forecast by Diagnosis Type
Table 9: Latin America Market US$ Mn Forecast by End User
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Diagnosis Type
Table 12: Western Europe Market US$ Mn Forecast by End User
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Diagnosis Type
Table 15: Eastern Europe Market US$ Mn Forecast by End User
Table 16: Asia Pacific Market US$ Mn Forecast by Country
Table 17: Asia Pacific Market US$ Mn Forecast by Diagnosis Type
Table 18: Asia Pacific Market US$ Mn Forecast by End User
Table 19: East Asia Market US$ Mn Forecast by Country
Table 20: East Asia Market US$ Mn Forecast by Diagnosis Type
Table 21: East Asia Market US$ Mn Forecast by End User
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Diagnosis Type
Table 24: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 4: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 7: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 8: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 17: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 18: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 20: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Diagnosis Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How Much is the High-Sensitivity Cardiac Biomarker Market likely to be Worth?
The high-sensitivity cardiac biomarker market size is currently valued at USD 16.04 Billion.
Why High-Sensitivity Cardiac Biomarker Market has High Growth Potential?
The size of the high-sensitivity cardiac biomarker market is likely to expand at a 14.7% CAGR during the forecast period.
Where will Manufacturers find Most Opportunities in the High-Sensitivity Cardiac Biomarker Market?
The North America region is likely to lead the high-sensitivity cardiac biomarker market.
High-Sensitivity Cardiac Biomarker Market